10-Q/A: FiEE, Inc. Restates Q2 2024 Financials Due to Share Count Errors, Revealing Significant Business Decline

Sentiment:

Quarterly Report Amendment


FiEE, Inc. has filed an amended quarterly report for Q2 2024 to correct errors in its common stock outstanding and earnings per share, alongside reporting a drastic decline in net sales and a shift to a stockholders' deficit.

Capital raiseThe company issued 2,000,000 shares of preferred stock for $1,358,573 during the six months ended June 30, 2024.Warrants were issued, contributing $1,441,427 to additional paid-in capital during the six months ended June 30, 2024.
Better than expectedThe restatement resulted in a numerically lower (less negative) net loss per share for both the three and six months ended June 30, 2024, compared to the original filing. For Q2 2024, net loss per share improved from $0.17 to $0.16. For H1 2024, it improved from $1.34 to $1.27.This improvement in the per-share metric is a direct result of correcting an error in the weighted average common shares outstanding, which increased the denominator in the loss per share calculation.

Summary

  • FiEE, Inc., formerly Minim, Inc., filed an Amendment No. 1 to its Quarterly Report on Form 10-Q for the period ended June 30, 2024, to restate certain financial statements.
  • The restatement was necessary due to errors in recording and reporting shares of the company's common stock outstanding, which impacted earnings per share calculations.
  • For the fiscal year ended December 31, 2023, the corrected outstanding shares of common stock are 2,789,020, an increase from the previously reported 2,632,809 shares.
  • For the period ended June 30, 2024, the corrected outstanding shares of common stock are 2,965,900, an increase from the previously reported 2,809,689 shares.
  • The error did not impact the period ended June 30, 2023.
  • For the three months ended June 30, 2024, the restated basic and diluted net loss per share is $0.16, compared to the original $0.17 per share.
  • For the six months ended June 30, 2024, the restated basic and diluted net loss per share is $1.27, compared to the original $1.34 per share.
  • Net sales for the three months ended June 30, 2024, were $0, a significant decrease from $7,194,757 in the same period of 2023.
  • Net sales for the six months ended June 30, 2024, were $639,893, a substantial decline from $17,946,541 in the same period of 2023.
  • The company reported a net loss of $487,912 for the three months ended June 30, 2024, and $3,746,867 for the six months ended June 30, 2024.
  • Total assets decreased significantly from $12,359,965 as of December 31, 2023, to $953,280 as of June 30, 2024.
  • Total liabilities decreased from $12,244,048 as of December 31, 2023, to $1,357,950 as of June 30, 2024.
  • Stockholders' equity shifted from a positive $115,917 as of December 31, 2023, to a deficit of $(404,669) as of June 30, 2024.
  • The company issued 2,000,000 shares of preferred stock for $1,358,573 and warrants for $1,441,427 during the six months ended June 30, 2024.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative. While the restatement technically resulted in a numerically 'better' (less negative) EPS, the underlying reason is an accounting error, indicating poor internal controls. More critically, the company experienced a near-total collapse in net sales and gross profit, a massive reduction in total assets, and a shift to a stockholders' deficit, signaling severe operational and financial distress.

Positives

  • The restatement resulted in a numerically lower (less negative) basic and diluted net loss per share for both the three months ($0.16 vs $0.17) and six months ($1.27 vs $1.34) ended June 30, 2024.
  • The company recognized vendor liability forgiveness, net of asset transfers, of $2,200,929 for the six months ended June 30, 2024.

Negatives

  • The necessity of restating previously filed financial statements due to errors in common stock outstanding indicates internal control deficiencies.
  • Net sales for the three months ended June 30, 2024, plummeted to $0 from $7,194,757 in the prior year period.
  • Net sales for the six months ended June 30, 2024, drastically declined to $639,893 from $17,946,541 in the prior year period.
  • Gross profit for the three and six months ended June 30, 2024, saw a significant reduction, reaching $0 and $207,259 respectively, compared to $485,900 and $3,095,103 in the prior year periods.
  • Total assets decreased by over 92% from $12,359,965 at December 31, 2023, to $953,280 at June 30, 2024.
  • The company's stockholders' equity shifted from a positive balance of $115,917 to a deficit of $(404,669) within six months.

Risks

  • Investors should no longer rely on the company's previously released financial statements for the period ended June 30, 2024, due to identified errors.
  • The restatement highlights potential weaknesses in the company's internal controls over financial reporting, which could lead to future inaccuracies.
  • The significant decline in sales and assets indicates severe operational challenges and potential going concern risks.

Future Outlook

The filing is an amendment to correct past financial statements and does not provide new forward-looking statements or guidance beyond the restated historical figures.

Industry Context

This filing primarily addresses internal accounting errors and significant financial deterioration specific to FiEE, Inc., rather than broader industry trends. The drastic decline in sales suggests a severe loss of market position or operational capacity within its sector.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Financial Statement Restatement OversightThe Audit Committee, in consultation with management, concluded that previously filed financial statements for the period ended June 30, 2024, should no longer be relied upon due to errors in recording and reporting common stock outstanding and earnings per share.June 30, 2024 (period ended)Indicates active oversight by the Audit Committee in identifying and correcting material financial reporting errors, but also highlights a failure in initial financial reporting accuracy.

Stakeholder Impact

  • Shareholders: The restatement impacts the accuracy of historical financial performance, potentially eroding confidence. The increase in outstanding shares affects per-share metrics.
  • Investors: The need for a restatement due to errors raises concerns about the reliability of the company's financial reporting and internal controls.
  • Management: The CEO and CFO have re-certified the amended financial statements, taking responsibility for the corrected disclosures.

Key Dates

DateDescription
December 31, 2022Balance sheet date for comparative stockholders' equity.
March 31, 2023Balance sheet date for comparative stockholders' equity.
June 30, 2023End of comparative quarterly period.
December 31, 2023Fiscal year-end for comparative balance sheet and corrected common stock outstanding.
March 31, 2024Balance sheet date for stockholders' equity.
June 30, 2024End of quarterly period for the amended report and corrected common stock outstanding.
August 20, 2024Original Form 10-Q filing date.
July 25, 2025Number of shares outstanding of common stock as of this date (6,224,389 shares).
July 28, 2025Filing date of the Form 10-Q/A amendment.

Recommendation

strong sell

The company's financial health has deteriorated severely, evidenced by a near-complete collapse in net sales and gross profit, a massive reduction in total assets, and a shift to a stockholders' deficit. The need for a restatement due to errors in share count further highlights significant internal control weaknesses and raises serious questions about the reliability of its financial reporting. Despite a numerically 'better' (less negative) EPS post-restatement, the underlying operational and financial performance is dire, making the stock a high-risk investment with substantial downside potential.

Keywords

FIEE, MINIM, 10-Q/A, Restatement, Financial Reporting, Common Stock, Earnings Per Share, SEC Filing, Quarterly Report, Financial Errors, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.